Our laboratory is primarily focused on elucidating the molecular mechanisms that enable cancer cells to develop resistance to multiple anticancer therapies. In particular, we investigate the TRIBBLES family of pseudokinases and their contribution to tumor initiation, progression, and therapeutic resistance.
The primary objective of our research group is to explore the pathophysiological mechanisms underlying various metabolic disorders, including obesity, fatty liver disease, insulin resistance, and type 2 diabetes. Our focus is on understanding how these conditions are influenced by factors such as ageing, physical activity, dietary habits, and weight reduction, particularly through bariatric and metabolic surgery as a treatment for obesity.
1. Characterizing the heterogeneity of the cognitive profiles among adults with dyslexia, to understand the mechanisms that enable certain individuals to compensate for their deficits and succeed in their academic lives. while others do not.
2.Continuing to deepen our knowledge about the time course of visual word recognition, both in typical readers and in readers with dyslexia, exploring the electroencephalographic component N170 as a marker of the sensitivity of the reading system to the orthographic characteristics of words.